vivoslife.com - VVOS Profit before deduction of interest, taxes, depreciation and amortization
This EBITDA chart demonstrates the financial trajectory of Vivos Therapeutics (VVOS), where 0.00 is the current value of the indicator. Revenues are based on the sale of systems for the non-surgical correction of jaw pathologies and the treatment of apnea. Prospects rely on creating a healthy sleep environment through the training of dentists. Stability is guaranteed by partnerships with dental laboratories while maintaining full patent ownership.
Summary analytical data breakdowns for Vivos Therapeutics, Inc. (VVOS)
- stock value and consensus price forecast:
- issuer market value details:
- book capitalization indicators:
- business debt structure and liquidity details:
All Debt to Shareholders' Equity Ratio Vivos Therapeutics|VVOS - Long-Term Debt to Equity|Short-Term Debt to Equity Ratio Vivos Therapeutics Inc.|VVOS - Company Aggregate Debts|Debts to Book Value Vivos Therapeutics|VVOS - Company Long-Term Debts|Company Short-Term Indebtedness Vivos Therapeutics|Interim Coverage Ratio vivoslife.com
- earnings and market multiples details:
VVOS - Net Profit|Future Profit Vivos Therapeutics|VVOS - P/E Multiple|Forward P/E Multiple vivoslife.com|VVOS - Price/Earnings to Growth Ratio|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Vivos Therapeutics|VVOS - Operating profit before deduction of amortization|Earnings per share for the trailing year Vivos Therapeutics|VVOS - Net earnings per share (EPS TTM)|Earnings per share growth in annualized terms for the last twelve months vivoslife.com|VVOS - Earnings per share growth in current year|Net earnings per one share growth forecast for next year Vivos Therapeutics
Summary company analytics:Vivos Therapeutics
The use of external contract laboratories and partner distribution for apnea treatment directly determines the operating expense structure of Vivos Therapeutics (VVOS). This metric measures net cash flow from core operations before depreciation, allowing for an assessment of the business's real-time daily efficiency; therefore, analyzing the company's consolidated EBITDA helps investors avoid freezing capital when purchasing the asset at local yield peaks.
Who Vivos Therapeutics competes with
Operating income before deduction of amortization Boston Scientific Corporation Inc. (BSX)|EW: Operating profit before deduction of amortization|Profit before deduction of interest, taxes, depreciation and amortization RMD|PODD: Operating profit EBITDA|Profit before interest, taxes and amortization Zimmer (ZBH)|COO (CooperVision) - Operating profit EBITDA|Operating profit before amortization ALGN (Align Corp)|Operating profit before deduction of amortization GMED (Globus Medical, Inc.)|TMDX (TransMedics Group, Inc.) - Income before deduction of interest, taxes and amortization|Profit before payment of interest, taxes and amortization Alphatec ATEC|AORT - Operating profit before deduction of amortization|DJO Global - Operating profit EBITDA|Profit before interest, taxes and amortization Integra LifeSciences Inc.|ESTA: Operating profit EBITDA|Operating profit before amortization BBNX|IRMD (IRADIMED) - Operating profit EBITDA|Embecta Corp (EMBC) - Operating income before deduction of amortization|Operating profit EBITDA TNDM|Operating profit before deduction of amortization Axogen Surgical AXGN|Operating profit EBITDA SIBN (SI-BONE, Inc.)|Operating profit EBITDA orthofix.com OFIX|BVS - Profit before payment of interest, taxes and amortization|KIDS: Profit before payment of interest, taxes and amortization|TMCI (Treace Medical) - Operating profit before deduction of amortization|Strata Medical - Income before deduction of interest, taxes and amortization|CARL (Carlsmed Inc) - Operating profit EBITDA|Profit before interest, taxes and amortization rxsight.com RXST|Profit before payment of interest, taxes and amortization ClearPoint Neuro, Inc. (CLPT)|Stereotaxis Inc (STXS) - Operating profit before depreciation charges|NeuroStar - Operating profit before deduction of amortization|Operating profit EBITDA Sight Sciences Inc SGHT|Orchestra BioMed, Inc. - Operating profit EBITDA|Operating income before deduction of amortization Anika Therapeutics ANIK|InspireMD (NSPR) - Profit before payment of interest, taxes and amortization|Profit before deduction of interest, taxes, depreciation and amortization ZJYL (Jin Medical)|Profit before payment of interest, taxes and amortization Vivani Medical Inc|Operating profit before deduction of amortization Xtant Medical Inc (XTNT)|Operating profit EBITDA NMTC|MODD - Profit before interest, taxes and amortization|Profit before payment of interest, taxes and amortization Myomo MYO|COCH: Operating profit before amortization|NVNO: Operating profit before deduction of amortization|Sintx Technologies - Company profit before taxes, interest and amortization|TNON (Tenon Medical, Inc.) - Operating profit before deduction of amortization|LFWD (rewalk.com) - Profit before payment of interest, taxes and amortization|AMIX (Autonomix Medical Inc.) - Operating profit EBITDA|INVO Bioscience (IVF) - Operating income before deduction of amortization|Operating profit before deduction of amortization BBLG (Bone Biologics Corporation)|Profit before payment of interest, taxes and amortization AXNX (Axonics, Inc)|Profit before payment of interest, taxes and amortization BIOLASE, Inc. BIOL|Dynatronics Corp (DYNT) - Profit before interest, taxes and amortization|FNA - Profit before payment of interest, taxes and amortization|Operating income before deduction of amortization INVO Bioscience, Inc. INVO
